Home Top Global NewsHealthcare Eli Lilly 2022 gains grow to 20% as it lays out plan for obesity drug, tirzepatide

Eli Lilly 2022 gains grow to 20% as it lays out plan for obesity drug, tirzepatide

by Ozva Admin

You may also like

Leave a Comment